Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) EBT Margin (2017 - 2025)

Assembly Biosciences (ASMB) has 8 years of EBT Margin data on record, last reported at 85.23% in Q3 2025.

  • For Q3 2025, EBT Margin rose 5520.0% year-over-year to 85.23%; the TTM value through Sep 2025 reached 103.85%, up 3865.0%, while the annual FY2024 figure was 139.72%, 71460.0% up from the prior year.
  • EBT Margin reached 85.23% in Q3 2025 per ASMB's latest filing, up from 105.94% in the prior quarter.
  • Across five years, EBT Margin topped out at 85.23% in Q3 2025 and bottomed at 300.66% in Q3 2021.
  • Average EBT Margin over 4 years is 144.76%, with a median of 140.44% recorded in 2024.
  • Peak YoY movement for EBT Margin: crashed -29098bps in 2021, then soared 6329bps in 2025.
  • A 4-year view of EBT Margin shows it stood at 300.66% in 2021, then surged by 49bps to 152.58% in 2023, then grew by 7bps to 141.51% in 2024, then surged by 40bps to 85.23% in 2025.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 85.23% in Q3 2025, 105.94% in Q2 2025, and 93.62% in Q1 2025.